[en] BACKGROUND: Insulin and multiple other autoantigens have been implicated in the pathogenesis of autoimmune type 1 diabetes, but the origin of immunological self-reactivity specifically oriented against insulin-secreting islet beta-cells remains obscure. The primary objective of the present study was to investigate the hypothesis that a defect in thymic central T-cell self-tolerance of the insulin hormone family could contribute to the pathophysiology of type 1 diabetes. This hypothesis was investigated in a classic animal model of type 1 diabetes, the Bio-Breeding (BB) rat. METHODS: The expression of the mammalian insulin-related genes (Ins, Igf1 and Igf2) was analysed in the thymus of inbred Wistar Furth rats (WF), diabetes-resistant BB (BBDR) and diabetes-prone BB (BBDP) rats. RESULTS: RT-PCR analyses of total RNA from WF, BBDP and BBDR thymi revealed that Igf1 and Ins mRNAs are present in 15/15 thymi from 2-day-old, 5-day-old and 5-week-old WF, BBDR and BBDP rats. In contrast, a complete absence of Igf2 mRNA was observed in more than 80% of BBDP thymi. The absence of detectable Igf2 transcripts in the thymus of BBDP rats is tissue-specific, since Igf2 mRNAs were detected in all BBDP brains and livers examined. Using a specific immunoradiometric assay, the concentration of thymic IGF-2 protein was significantly lower in BBDP than in BBDR rats (p<0.01). CONCLUSIONS: The present study suggests an association between the emergence of autoimmune diabetes and a defect in Igf2 expression in the thymus of BBDP rats. This tissue-specific defect in gene expression could contribute both to the lymphopenia of these rats (by impaired T-cell development) and the absence of central T-cell self-tolerance of the insulin hormone family (by defective negative selection of self-reactive T-cells).
Semple J.W., Lang Y., Speck E.R., Delovitch T.L. (1992) Processing and presentation of insulin. III. Insulin degrading enzyme: A neutral metalloendoproteinase that is non-homologous to classical endoproteinases mediates the processing of insulin epitopes for helper T cells. Int Immunol 4:1161-1167.
Wegmann D.R., Gill R.G., Norbury-Glaser M., Schloot N., Daniel D. (1994) Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 7:833-843.
Rudy G., Stone N., Harrison L.C. (1995) Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1:625-633.
Griffin A.C., Zhao W., Wegmann K.W., Hickley W.F. (1995) Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin. Am J Pathol 147:845-857.
Martens H., Goxe B., Geenen V. (1996) The thymic repertoire of neuroendocrine self-antigens: Physiological implications in T-cell life and death. Immunol Today 17:312-317.
Geenen V., Lefebvre P.J. (1998) The intrathymic expression of insulin-related genes: Implications for pathophysiology and prevention of type 1 diabetes. Diabetes Metab Rev 14:95-103.
Geenen V., Kecha O., Martens H. (1998) Thymic expression of neuroendocrine self-peptide precursors: Role in T cell survival and self-tolerance. J Neuroendocrinol 10:811-822.
Kisielow P., Bluthmann H., Staerz U.D., Steinmetz M., von Boehmer H. (1988) Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742-746.
Bonomo A., Matzinger P. (1993) Thymus epithelium induces tissue-specific tolerance. J Exp Med 177:1153-1164.
Sprent J. (1995) Central tolerance of T cells. Int Rev Immunol 13:95-105.
Geenen V., Achour I., Robert F. (1993) Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus 21:115-127.
Arkins S., Rebeiz N., Biragyn A., Reese D., Kelley K. (1993) Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology 133:2334-2343.
Van der Ven L.T., Roholl P.J., Reijnen-Gresnigt M.G., Bloemen R.J., van Buul-Offers S.C. (1997) Expression of insulin-like growth factor II (IGF-II) and histological changes in the thymus and spleen of transgenic mice overexpressing IGF-II. Histochem Cell Biol 107:193-203.
Kecha O., Martens H., Franchimont N. (1999) Characterization of the insulin-like growth factor axis in the human thymus. J Neuroendocrinol 11:435-440.
Kecha O., Brilot F., Martens H. (2000) Involvement of insulin-like growth factors in early T cell development: A study using fetal thymic organ cultures. Endocrinology 141:1209-1217.
Jolicoeur C., Hanahan D., Smith K.M. (1994) T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci U S A 91:6707-6711.
Vafiadis P., Bennett S.T., Todd J.A. (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289-292.
Pugliese A., Zeller M., Fernandez A. (1997) The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293-297.
Throsby M., Homo-Delarche F., Chevenne D., Goya R., Dardenne M., Pleau J.M. (1998) Pancreatic hormone expression in the murine thymus: Localization in dendritic cells and macrophages. Endocrinology 139:2399-2406.
Heath V.L., Moore N.C., Parnell S.M., Mason D.W. (1998) Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun 11:309-318.
Mordes J.P., Bortell R., Doukas J. (1996) The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes Metab Rev 12:103-109.
Schechter R., Beju D., Gaffney T., Schaefer F., Whetsell L. (1996) Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system. Brain Res 736:16-27.
Purnelle G., Gerard A., Czajkowski V., Bourguignon J.P. (1997) Pulsatile secretion of gonadotropin-releasing hormone by rat hypothalamic explants without cell bodies of GnRH neurons. Neuroendocrinology , [corrected] [published erratum appears in Neuroendocrinology 1998; 67: 57]; 66:305-312.
Miles L.E., Lipschitz D.A., Bieber C.P., Cook J.D. (1974) Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 61:209-224.
Bach J.F. (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542.
Doukas J., Mordes J.P., Swymer C. (1994) Thymic epithelial defects and predisposition to autoimmune disease in BB rats. Am J Pathol 145:1517-1525.
Whalen B.J., Weiser P., Marounek J., Rossini A.A., Mordes J.P., Greiner D.L. (1999) Recapitulation of normal and abnormal BioBreeding rat T cell development in adult thymus organ culture. J Immunol 162:4003-4012.
Bieg S., Moller C., Olsson T., Lernmark A. (1997) The lymphopenia (lyp) gene controls the intrathymic cytokine ratio in congenic BioBreeding rats. Diabetologia 40:786-792.
Soares M.B., Ishii D.N., Efstratiadis A. (1985) Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA. Nucleic Acids Res 13:1119-1134.
Soares M.B., Turken A., Ishii D. (1986) Rat insulin-like growth factor II gene. A single gene with two promoters expressing a multitranscript family. J Mol Biol 192:737-752.
Graham D.E., Rechler M.M., Brown A.L. (1986) Coordinate developmental regulation of high and low molecular weight mRNAs for rat insulin-like growth factor II. Proc Natl Acad Sci U S A 83:4519-4523.
Frunzio R., Chiariotti L., Brown A.L., Graham D.E., Rechler M.M., Bruni C.B. (1986) Structure and expression of the rat insulin-like growth factor II (rIGF- II) gene. Rigf-II RNAs are transcribed from two promoters. J Biol Chem 261:17138-17149.
Brown A.L., Graham D.E., Nissley S.P., Hill D.J., Strain A.J., Rechler M.M. (1986) Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. J Biol Chem 261:13144-13150.
Lund P.K., Moats-Staats B.M., Hynes M.A. (1986) Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 261:14539-14544.
Rotwein P., Pollock K.M., Watson M., Milbrandt J.D. (1987) Insulin-like growth factor gene expression during rat embryonic development. Endocrinology 121:2141-2144.
Gray A., Tam A.W., Dull T.J. (1987) Tissue-specific and developmentally regulated transcription of the insulin-like growth factor 2 gene. DNA 6:283-295.
Stylianopoulou F., Herbert J., Soares M.B., Efstratiadis A. (1988) Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci U S A 85:141-145.
Crisa L., Mordes J.P., Rossini A.A. (1992) Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev 8:4-37.
Martin A.M., Maxson M.N., Leif J., Mordes J.P., Greiner D.L., Blankenhorn E.P. (1999) Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4. Additional evidence for a "universal autoimmunity locus" on rat chromosome 4. Diabetes 48:2138-2144.
Martin A.M., Blankenhorn E.P., Maxson M.N. (1999) Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes 48:50-58.
Kloting I., Schmidt S., Kovacs P. (1998) Mapping of novel genes predisposing or protecting diabetes development in the BB/OK rat. Biochem Biophys Res Commun 245:483-486.
Bennett S.T., Wilson A.J., Cucca F. (1996) IDDM2-VNTR-encoded susceptibility to type 1 diabetes: Dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun 9:415-421.
Vafiadis P., Bennett S.T., Todd J.A., Grabs R., Polychronakos C. (1998) Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes. J Clin Endocrinol Metab 83:2933-2939.
Paquette J., Giannoukakis N., Polychronakos C., Vafiadis P., Deal C. (1998) The INS 5′ variable number of tandem repeats is associated with IGF2 expression in humans. J Biol Chem 273:14158-14164.
Pozzilli P., Pitocco D., Visalli N. (2000) No effect of oral insulin on residual beta-cell function in recent-onset type 1 diabetes. Diabetologia 43:1000-1004.
Chaillous L., Lefevre H., Thivolet C. (2000) Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: A multicentre randomised controlled trial. Lancet , Diabetes Insulin Oral Group; 356:545-549.
